Design, synthesis and molecular modeling studies of thiosemicarbazide & thiazolyl-hydrazone derivatives as potential anticancer agents and topoisomerase inhibitors
作者:Sevil Şenkardeş、İrfan Bolat、Hazal Şahinbey、Sevgi Karakuş、Ömer Erdoğan、Pakize Cantürk、Serap Yılmaz Özgüven、Özge Çevik
DOI:10.1016/j.molstruc.2024.137488
日期:2024.4
This study involved the design, synthesis and evaluation of a series of novel thiosemicarbazide and thiazolyl-hydrazone derivatives. The synthesized compounds were tested for cytotoxic effects SH-SY5Y neuroblastoma cells, as well as NIH-3T3 normal cell line using the MTT assay. Among the tested compounds, and exhibited IC values ranging from 1.97 µM to 3.22 µM in the SH-SY5Y cancer cell line with lower
本研究涉及一系列新型氨基硫脲和噻唑基腙衍生物的设计、合成和评价。使用 MTT 法测试合成的化合物对 SH-SY5Y 神经母细胞瘤细胞以及 NIH-3T3 正常细胞系的细胞毒性作用。在测试的化合物中, 和 在 SH-SY5Y 癌细胞系中的 IC 值范围为 1.97 µM 至 3.22 µM,对 NIH-3T3 细胞具有较低的细胞毒性。此外,还筛选了所有化合物的拓扑异构酶I和II抑制活性,化合物完全抑制拓扑异构酶I酶,而所有化合物均显示出有效的拓扑异构酶II抑制活性。进行对接研究以确定测试化合物与拓扑异构酶 I 和 II 活性位点的结合模式。总之,-(4-(2-((2-氯苯基)硫氨基甲酰基)肼-1-羰基)苯基)苯甲酰胺(作为拓扑异构酶 I 和 II 的有前途的抑制剂而出现,并具有作为寻找新型拓扑异构酶的先导化合物的潜力。抗癌剂。